Diabetes

Presented during ADA’s 80th Scientific Sessions, results from an analysis of a 6-month telehealth intervention showed sustained improvements in glycemic control in patients with diabetes.

An analysis focused on patients with type 2 diabetes in rural regions, where accessibility to physicians is often limited.

Pharmacists must be tuned in to the latest technology for patients who monitor blood glucose.

Carla Cox, PhD, registered dietician and certified diabetes educator, discusses key information about COVID-19 that individuals with diabetes should know.

This is the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy for individuals with high cardiovascular risk but without prior instances of heart attack or stroke.

Apotex Corp is voluntarily recalling all lots of metformin hydrochloride extended-release tablets, USP 500 mg, within expiry to retail level.

CMS is reducing insulin copays for seniors who are eligible for Medicare via an executive order from President Donald Trump.

Months after FDA said it was investigating the carcinogenic ingredient NDMA in metformin products, the agency’s testing has found elevated levels of NDMA in extended release metformin, but not in the immediate release formulation. 

A new study suggests that well-controlled blood sugar may reduce mortality for patients with diabetes and COVID-19.

A new study evaluated methods of improving heart function in individuals with type 2 diabetes.

Insulin manufacturers are expanding insulin affordability options for patients with diabetes during the coronavirus pandemic. 

The American Heart Association’s scientific statement outlines medications, procedures, and lifestyle change recommendations for individuals with both type2 diabetes and coronary artery disease.

V-Go® may provide a more affordable option for insulin therapy.

Pharmacists can play an integral role in managing patients with diabetes.

The successful maiden flight of an autonomous drone delivering insulin shows the potential for drone use in the delivery of lifesaving medications and supplies during disasters.

A clinical trial funded by AstraZeneca evaluated the use of short-acting GLP-1 receptor agonists as an add-on treatment to insulin therapy in type 1 diabetes.

Ticagrelor alone, without aspirin, reduced bleeding without increasing the cardiovascular risks.

The updated labeling recommends temporary discontinuation of SGLT2 inhibitors before scheduled surgery.

Creating a place where patients seek diabetes care and counseling.

The CDC’s 2020 National Diabetes Statistics Report outlines the current state of the disease.

Patient access to portal self-management tools through mobile devices may help significantly improve diabetes care.

The FreeStyle Libre system decreased HbA1c, increased time in glucose range, and reduced diabetes complications.

The pharmacist’s role in diabetes management is more important than ever before, given the number of patients with diabetes and the number of options available for treating them.

Novo Nordisk has fired the first “shot heard around the health care world.”

Rosiglitazone, which is used to treat type 2 diabetes, may increase the risk of heart problems.

Fresenius Kabi’s glucagon emergency kit is a cost-effective alternative to branded kit products.

The FDA posted results of its NDMA lab analysis of metformin products in the United States.

SGLT2 inhibitor therapy provided protective effects from cardiovascular (CV) events in patients with type 2 diabetes with or without established CV disease.

Eli Lilly plans to donate at least 200,000 KwikPens of its insulin to support lower-income communities.

Older adults with diabetes are experiencing declines in all-cause mortality rates, whereas younger adults continue to be affected more by the condition.